対話型分析
マクロ分析
個別銘柄
アルファラボ
ユーティリティ
Menu
JA
ログイン
JA
急騰分析
/
Zentalis Pharmaceuticals, Inc.
/
2026-04-09
▲ SURGE
Zentalis Pharmaceuticals, Inc.
+60.1%
ZNTL
NASDAQ
Healthcare
2026-04-09
4.42
終値
2.76
前日終値
+60.14%
騰落率
19.0x
出来高比
急騰の理由
2026년 3월 27일 H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 등급을 재확인하고 목표 주가를 10달러로 유지했습니다.
·
2026년 3월 27일 H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 등급을 재확인하고 목표 주가를 10달러로 유지했습니다.
関連ニュース
Zenas BioPharma Prices $300M Concurrent Offerings Of $200M 2.50% Convertible Senior Notes Due 2032 And 5M Shares At $20 To Fund Obexelimab Launch - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga
2026-03-27
Zoetis Inc (ZTS) Stock Price Down 3.29% on Mar 18
Gurufocus
2026-03-18
H.C. Wainwright reiterates Zentalis stock rating, $10 target By Investing
Au.Investing
2026-03-27
HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga
2026-03-17
Nektar stock up on trial data for eczema drug (NKTR:NASDAQ)
Seekingalpha
2026-02-10
テクニカル分析
シグナル
BB上抜け
買われすぎ
MACD強気
SMA20上
主要指標
77.86
RSI (14)
2.66
SMA 20
1.75
Bollinger Lower
3.57
Bollinger Upper
2.66
Bollinger Mid
0.16
MACD
0.03
MACD Signal
0.14
MACD Hist
銘柄詳細を見る
急騰銘柄一覧へ
Zentalis Pharmaceuticals, Inc. +60.1% 急騰分析 (2026-04-09) | Alpha Lenz